Auristatin mit einem Heilmittel bindenden Konjugat

Patent europeic · EP2842575 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2842575
Numer da la dumonda
EP14182732
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
18-03-2009
Publitgà
04-03-2015
Concedì
27-09-2017
Stritgà
24-10-2025
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 47/65 (2017.01)
A61K 47/68 (2017.01)
C07K 5/02 (2006.01)
A61K 38/00 (2006.01)
Prioritad
US 37705 P 18.03.2008
US 44431 P 11.04.2008
Derivà da
EP09721267
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-10-2025

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    24.10.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 24.10.2025

  2. 02-04-2024

    Midada

    Published in Swissreg on 02.04.2024

  3. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  4. 01-06-2021

    Adressa midada

    Owner
    Seattle Genetics, Inc., 21823 30th Drive, S.E., Bothell, WA 98021, USA → Seagen Inc., 21823 30th Drive, S.E., Bothell, WA 98021, USA

    Published in Swissreg on 01.06.2021

  5. 27-09-2017

    Concedì

    Published in Swissreg on 27.09.2017

Partidas

Inventur

Senter, Peter

Bothell, WA 98021, US

Doronina, Svetlana

Bothell, WA 98021, US

Bovee, Timothy

Bothell, WA 98021, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.